{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T09:26:58Z","timestamp":1771579618068,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T00:00:00Z","timestamp":1440460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T00:00:00Z","timestamp":1440460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Discov"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The human induced pluripotent stem cell (iPSC) technique promises to provide an unlimited, reliable source of genetically matched pluripotent cells for personalized therapy and disease modeling. Recently, it is observed that cells with ring chromosomes 13 or 17 autonomously correct the defects via compensatory uniparental disomy during cellular reprogramming to iPSCs. This breakthrough finding suggests a potential therapeutic approach to repair large-scale chromosomal aberrations. However, due to the scarceness of ring chromosome samples, the reproducibility of this approach in different individuals is not carefully evaluated yet. Moreover, the underlying mechanism and the applicability to other types of chromosomal aberrations remain unknown. Here we generated iPSCs from four 45,X chorionic villous fibroblast lines and found that only one reprogrammed line acquired 46,XX karyotype via uniparental disomy of the entire X chromosome. The karyotype correction was reproducible in the same cell line by either retroviral or episomal reprogramming. The karyotype-corrected iPSCs were subject to X chromosome inactivation and obtained better colony morphology and higher proliferation rate than other uncorrected ones. Further transcriptomic comparison among the fibroblast lines identified a distinct expression pattern of cell cycle regulators in the uncorrectable ones. These findings demonstrate that the iPSC technique holds the potential to correct X monosomy, but the correction rate is very low, probably due to differential regulation of cell cycle genes between individuals. Our data strongly suggest that more systematic investigations are needed before defining the iPSC technique as a novel means of chromosome therapy.<\/jats:p>","DOI":"10.1038\/celldisc.2015.22","type":"journal-article","created":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T10:12:31Z","timestamp":1440497551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Uniparental disomy of the entire X chromosome in Turner syndrome patient-specific induced pluripotent stem cells"],"prefix":"10.1038","volume":"1","author":[{"given":"Yumei","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangye","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bolan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaoyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,25]]},"reference":[{"key":"BFcelldisc201522_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/hmg\/ddr435","volume":"21","author":"W Li","year":"2012","unstructured":"Li W, Wang X, Fan W et al. Modeling abnormal early development with induced pluripotent stem cells from aneuploid syndromes. Hum Mol Genet 2012; 21: 32\u201345.","journal-title":"Hum Mol Genet"},{"key":"BFcelldisc201522_CR2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861\u2013872.","journal-title":"Cell"},{"key":"BFcelldisc201522_CR3","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917\u20131920.","journal-title":"Science"},{"key":"BFcelldisc201522_CR4","doi-asserted-by":"publisher","first-page":"17567","DOI":"10.1073\/pnas.1215468109","volume":"109","author":"GA Maclean","year":"2012","unstructured":"Maclean GA, Menne TF, Guo G et al. Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells. Proc Natl Acad Sci USA 2012; 109: 17567\u201317572.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcelldisc201522_CR5","doi-asserted-by":"publisher","first-page":"9962","DOI":"10.1073\/pnas.1216575110","volume":"110","author":"JP Weick","year":"2013","unstructured":"Weick JP, Held DL, Bonadurer GF 3rd et al. Deficits in human trisomy 21 iPSCs and neurons. Proc Natl Acad Sci USA 2013; 110: 9962\u20139967.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcelldisc201522_CR6","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1038\/ncomms5430","volume":"5","author":"C Chen","year":"2014","unstructured":"Chen C, Jiang P, Xue H et al. Role of astroglia in Down's syndrome revealed by patient-derived human-induced pluripotent stem cells. Nat Commun 2014; 5: 4430.","journal-title":"Nat Commun"},{"key":"BFcelldisc201522_CR7","doi-asserted-by":"publisher","first-page":"6432","DOI":"10.1038\/srep06432","volume":"4","author":"AA Dominguez","year":"2014","unstructured":"Dominguez AA, Chiang HR, Sukhwani M, Orwig KE, Reijo Pera RA . Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies. Sci Rep 2014; 4: 6432.","journal-title":"Sci Rep"},{"key":"BFcelldisc201522_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nature12394","volume":"500","author":"J Jiang","year":"2013","unstructured":"Jiang J, Jing Y, Cost GJ et al. Translating dosage compensation to trisomy 21. Nature 2013; 500: 296\u2013300.","journal-title":"Nature"},{"key":"BFcelldisc201522_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nature12618","volume":"503","author":"A Shcheglovitov","year":"2013","unstructured":"Shcheglovitov A, Shcheglovitova O, Yazawa M et al. SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature 2013; 503: 267\u2013271.","journal-title":"Nature"},{"key":"BFcelldisc201522_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature12923","volume":"507","author":"M Bershteyn","year":"2014","unstructured":"Bershteyn M, Hayashi Y, Desachy G et al. Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells. Nature 2014; 507: 99\u2013103.","journal-title":"Nature"},{"key":"BFcelldisc201522_CR11","first-page":"514709","volume":"2015","author":"Y Luo","year":"2015","unstructured":"Luo Y, Zhu D, Zhang Z, Chen Y, Sun X . Integrative analysis of CRISPR\/Cas9 target sites in the human HBB gene. BioMed Res Int 2015; 2015: 514709.","journal-title":"BioMed Res Int"},{"key":"BFcelldisc201522_CR12","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJM199612053352307","volume":"335","author":"P Saenger","year":"1996","unstructured":"Saenger P . Turner's syndrome. N Engl J Med 1996; 335: 1749\u20131754.","journal-title":"N Engl J Med"},{"key":"BFcelldisc201522_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0140-6736(01)05487-3","volume":"358","author":"MB Ranke","year":"2001","unstructured":"Ranke MB, Saenger P . Turner's syndrome. Lancet 2001; 358: 309\u2013314.","journal-title":"Lancet"},{"key":"BFcelldisc201522_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nature03479","volume":"434","author":"L Carrel","year":"2005","unstructured":"Carrel L, Willard HF . X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005; 434: 400\u2013404.","journal-title":"Nature"},{"key":"BFcelldisc201522_CR15","doi-asserted-by":"publisher","first-page":"e4175","DOI":"10.1371\/journal.pone.0004175","volume":"4","author":"A Urbach","year":"2009","unstructured":"Urbach A, Benvenisty N . Studying early lethality of 45,XO. Turner's syndrome) embryos using human embryonic stem cells. PLoS One 2009; 4: e4175.","journal-title":"PLoS One"},{"key":"BFcelldisc201522_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cell.2007.03.014","volume":"129","author":"JM Galan-Caridad","year":"2007","unstructured":"Galan-Caridad JM, Harel S, Arenzana TL et al. Zfx controls the self-renewal of embryonic and hematopoietic stem cells. Cell 2007; 129: 345\u2013357.","journal-title":"Cell"},{"key":"BFcelldisc201522_CR17","first-page":"4","volume":"31","author":"N Canki","year":"1988","unstructured":"Canki N, Warburton D, Byrne J . Morphological characteristics of monosomy X in spontaneous abortions. Ann Genet 1988; 31: 4\u201313.","journal-title":"Ann Genet"},{"key":"BFcelldisc201522_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nbt1285","volume":"25","author":"DE Baker","year":"2007","unstructured":"Baker DE, Harrison NJ, Maltby E et al. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol 2007; 25: 207\u2013215.","journal-title":"Nat Biotechnol"},{"key":"BFcelldisc201522_CR19","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.stemcr.2014.04.003","volume":"2","author":"KY Kim","year":"2014","unstructured":"Kim KY, Hysolli E, Tanaka Y et al. X Chromosome of female cells shows dynamic changes in status during human somatic cell reprogramming. Stem Cell Rep 2014; 2: 896\u2013909.","journal-title":"Stem Cell Rep"},{"key":"BFcelldisc201522_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/ng.2530","volume":"45","author":"C Vallot","year":"2013","unstructured":"Vallot C, Huret C, Lesecque Y et al. XACT, a long noncoding transcript coating the active X chromosome in human pluripotent cells. Nat Genet 2013; 45: 239\u2013241.","journal-title":"Nat Genet"},{"key":"BFcelldisc201522_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/2045-3701-4-74","volume":"4","author":"Y Luo","year":"2014","unstructured":"Luo Y, Li J, Zhu D, Fan Y, Li S, Sun X . High-resolution chromosomal microarray analysis of early-stage human embryonic stem cells reveals an association between X chromosome instability and skewed X inactivation. Cell Biosci 2014; 4: 74.","journal-title":"Cell Biosci"},{"key":"BFcelldisc201522_CR22","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1242\/dev.124.11.2275","volume":"124","author":"SW Luoh","year":"1997","unstructured":"Luoh SW, Bain PA, Polakiewicz RD et al. Zfx mutation results in small animal size and reduced germ cell number in male and female mice. Development 1997; 124: 2275\u20132284.","journal-title":"Development"},{"key":"BFcelldisc201522_CR23","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/hmg\/ddt500","volume":"23","author":"Y Tanaka","year":"2014","unstructured":"Tanaka Y, Kim KY, Zhong M, Pan X, Weissman SM, Park IH . Transcriptional regulation in pluripotent stem cells by methyl CpG-binding protein 2. MeCP2. Hum Mol Genet 2014; 23: 1045\u20131055.","journal-title":"Hum Mol Genet"},{"key":"BFcelldisc201522_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1750-1172-4-4","volume":"4","author":"D Sanlaville","year":"2009","unstructured":"Sanlaville D, Schluth-Bolard C, Turleau C . Distal Xq duplication and functional Xq disomy. Orphanet J Rare Dis 2009; 4: 4.","journal-title":"Orphanet J Rare Dis"},{"key":"BFcelldisc201522_CR25","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.4161\/cc.19724","volume":"11","author":"V Archambault","year":"2012","unstructured":"Archambault V, Carmena M . Polo-like kinase-activating kinases: Aurora A, Aurora B and what else? Cell Cycle 2012; 11: 1490\u20131495.","journal-title":"Cell Cycle"},{"key":"BFcelldisc201522_CR26","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00018-012-1073-7","volume":"70","author":"AS Nikonova","year":"2013","unstructured":"Nikonova AS, Astsaturov I, Serebriiskii IG, Dunbrack RL Jr, Golemis EA . Aurora A kinase (AURKA) in normal and pathological cell division. Cell Mol Life Sci 2013; 70: 661\u2013687.","journal-title":"Cell Mol Life Sci"},{"key":"BFcelldisc201522_CR27","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature12507","volume":"502","author":"L Kabeche","year":"2013","unstructured":"Kabeche L, Compton DA . Cyclin A regulates kinetochore microtubules to promote faithful chromosome segregation. Nature 2013; 502: 110\u2013113.","journal-title":"Nature"},{"key":"BFcelldisc201522_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/molehr\/gaq065","volume":"17","author":"Q Shi","year":"2011","unstructured":"Shi Q, Hu M, Luo M et al. Reduced expression of Mad2 and Bub1 proteins is associated with spontaneous miscarriages. Mol Hum Reprod 2011; 17: 14\u201321.","journal-title":"Mol Hum Reprod"},{"key":"BFcelldisc201522_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/sj.bjc.6603537","volume":"96","author":"M Damelin","year":"2007","unstructured":"Damelin M, Bestor TH . The decatenation checkpoint. Br J Cancer 2007; 96: 201\u2013205.","journal-title":"Br J Cancer"},{"key":"BFcelldisc201522_CR30","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.stem.2010.07.017","volume":"7","author":"Y Mayshar","year":"2010","unstructured":"Mayshar Y, Ben-David U, Lavon N et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010; 7: 521\u2013531.","journal-title":"Cell Stem Cell"},{"key":"BFcelldisc201522_CR31","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/(SICI)1521-1878(200005)22:5<452::AID-BIES7>3.0.CO;2-K","volume":"22","author":"WP Robinson","year":"2000","unstructured":"Robinson WP . Mechanisms leading to uniparental disomy and their clinical consequences. Bioessays 2000; 22: 452\u2013459.","journal-title":"Bioessays"},{"key":"BFcelldisc201522_CR32","first-page":"160","volume":"60","author":"F Quan","year":"1997","unstructured":"Quan F, Janas J, Toth-Fejel S, Johnson DB, Wolford JK, Popovich BW . Uniparental disomy of the entire X chromosome in a female with Duchenne muscular dystrophy. Am J Hum Genet 1997; 60: 160\u2013165.","journal-title":"Am J Hum Genet"},{"key":"BFcelldisc201522_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/jmg.35.7.539","volume":"35","author":"T Yorifuji","year":"1998","unstructured":"Yorifuji T, Muroi J, Kawai M et al. Uniparental and functional X disomy in Turner syndrome patients with unexplained mental retardation and X derived marker chromosomes. J Med Genet 1998; 35: 539\u2013544.","journal-title":"J Med Genet"},{"key":"BFcelldisc201522_CR34","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000071604","volume":"99","author":"T Kubota","year":"2002","unstructured":"Kubota T, Wakui K, Nakamura T et al. The proportion of cells with functional X disomy is associated with the severity of mental retardation in mosaic ring X Turner syndrome females. Cytogenet Genome Res 2002; 99: 276\u2013284.","journal-title":"Cytogenet Genome Res"},{"key":"BFcelldisc201522_CR35","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1084\/jem.20100797","volume":"207","author":"R Sarig","year":"2010","unstructured":"Sarig R, Rivlin N, Brosh R et al. Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells. J Exp Med 2010; 207: 2127\u20132140.","journal-title":"J Exp Med"},{"key":"BFcelldisc201522_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.molmed.2009.01.005","volume":"15","author":"M Tuna","year":"2009","unstructured":"Tuna M, Knuutila S, Mills GB . Uniparental disomy in cancer. Trends Mol Med 2009; 15: 120\u2013128.","journal-title":"Trends Mol Med"},{"key":"BFcelldisc201522_CR37","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1158\/0008-5472.CAN-04-3465","volume":"65","author":"SM Sirchia","year":"2005","unstructured":"Sirchia SM, Ramoscelli L, Grati FR et al. Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells. Cancer Res 2005; 65: 2139\u20132146.","journal-title":"Cancer Res"},{"key":"BFcelldisc201522_CR38","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1158\/0008-5472.CAN-07-0465","volume":"67","author":"A Vincent-Salomon","year":"2007","unstructured":"Vincent-Salomon A, Ganem-Elbaz C, Mani\u00e9 E et al. X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors. Cancer Res 2007; 67: 5134\u20135140.","journal-title":"Cancer Res"},{"key":"BFcelldisc201522_CR39","doi-asserted-by":"publisher","first-page":"6163","DOI":"10.1038\/sj.onc.1207808","volume":"23","author":"T Kawakami","year":"2004","unstructured":"Kawakami T, Zhang C, Taniguchi T et al. Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells. Oncogene 2004; 23: 6163\u20136169.","journal-title":"Oncogene"},{"key":"BFcelldisc201522_CR40","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1038\/mt.2013.123","volume":"21","author":"D Zhu","year":"2013","unstructured":"Zhu D, Lam DH, Purwanti YI et al. Systemic delivery of fusogenic membrane glycoprotein-expressing neural stem cells to selectively kill tumor cells. Mol Ther 2013; 21: 1621\u20131630.","journal-title":"Mol Ther"},{"key":"BFcelldisc201522_CR41","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1089\/hum.2013.160","volume":"25","author":"D Zhu","year":"2014","unstructured":"Zhu D, Chen C, Purwanti YI et al. Induced pluripotent stem cell-derived neural stem cells transduced with baculovirus encoding CD40 ligand for immunogene therapy in mouse models of breast cancer. Hum Gene Ther 2014; 25: 747\u2013758.","journal-title":"Hum Gene Ther"},{"key":"BFcelldisc201522_CR42","first-page":"751397","volume":"2014","author":"Y Luo","year":"2014","unstructured":"Luo Y, Zhu D . Combinatorial control of transgene expression by hypoxia-responsive promoter and microrna regulation for neural stem cell-based cancer therapy. Biomed Res Int 2014; 2014: 751397.","journal-title":"Biomed Res Int"},{"key":"BFcelldisc201522_CR43","doi-asserted-by":"publisher","first-page":"649080","DOI":"10.1155\/2015\/649080","volume":"2015","author":"Y Luo","year":"2015","unstructured":"Luo Y, Zhu D, Lam DH et al. A double-switch cell fusion-inducible transgene expression system for neural stem cell-based antiglioma gene therapy. Stem Cells Int 2015, 2015: 649080.","journal-title":"Stem Cells Int"}],"container-title":["Cell Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/celldisc201522.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/celldisc201522","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/celldisc201522.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T10:16:38Z","timestamp":1672913798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/celldisc201522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,25]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,29]]}},"alternative-id":["BFcelldisc201522"],"URL":"https:\/\/doi.org\/10.1038\/celldisc.2015.22","relation":{},"ISSN":["2056-5968"],"issn-type":[{"value":"2056-5968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,25]]},"assertion":[{"value":"4 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15022"}}